Showing results (1691-1700 of 1,824) with videos related to
Sort By:
Pageof 183
International Journal of Clinical Oncology|August 10, 2017
Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinomaHo Won Kang, Sung Pil Seo, Won Tae Kim, et al.Histology and Histopathology|May 29, 2009
Expression of beta-catenin and its mechanism of delocalization in intestinal-type early gastric cancer based on mucin expressionSoo Han Lee, Hyun Jeong Kang, Dong-Hun Shin, et al.ACS Applied Materials & Interfaces|February 28, 2022
High Entropy Oxide Relaxor FerroelectricsYogesh Sharma, Min-Cheol Lee, Krishna Chaitanya Pitike, et al.European Journal of Cancer (Oxford, England : 1990)|August 31, 2021
Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3)Se-Il Go, Sang-Cheol Lee, Woo Kyun Bae, et al.Nutrition and Cancer|September 21, 2018
Prognostic Impact of Nutritional Status Assessed by the Controlling Nutritional Status (CONUT) Score in Patients with Surgically Treated Renal Cell CarcinomaHo Won Kang, Sung Pil Seo, Won Tae Kim, et al.Physical Review Letters|April 26, 2018
Charge-Spin Correlation in van der Waals Antiferromagnet NiPS_{3}So Yeun Kim, Tae Yun Kim, Luke J Sandilands, et al.Cell Death & Disease|May 19, 2017
Acyl-CoA thioesterase 7 is involved in cell cycle progression via regulation of PKCζ-p53-p21 signaling pathwaySeung Hee Jung, Hyung Chul Lee, Hyun Jung Hwang, et al.International Journal of Cardiology|October 4, 2015
Comparison of transradial and transfemoral coronary intervention in octogenarians with acute myocardial infarctionHye Won Lee, Kwang Soo Cha, Jinhee Ahn, et al.Journal of Surgical Oncology|April 15, 2016
Surgical margin does not influence recurrence rate in pT1 clear cell renal cell carcinoma after partial nephrectomy: A multicenter studyHo Won Kang, Sang Keun Lee, Won Tae Kim, et al.Cells|May 13, 2023
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY TrialCheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, et al.Pageof 183